Tumor Infiltrating Leukocyte Density Is Independent of Tumor Grade and Molecular Subtype in Aggressive Breast Cancer of Western Kenya

Tropical Medicine and Health - United Kingdom
doi 10.1186/s41182-017-0059-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Impact of a Tumor-Infiltrating Lymphocyte Subtype in Triple Negative Cancer of the Breast

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2020English

Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2017English

An Independent Poor-Prognosis Subtype of Breast Cancer Defined by a Distinct Tumor Immune Microenvironment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Activated Tumor-Infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients

Journal of Cancer
Oncology
2018English

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women Over 70 Years of Age

Cancers
Cancer ResearchOncology
2020English

The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated With an Aggressive Tumor Phenotype

Clinical Cancer Research
Cancer ResearchOncology
2009English

Multi-Panel Immunofluorescence Analysis of Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer: Evolution of Tumor Immune Profiles and Patient Prognosis

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy